GENEVA, July 2 -- SKYHAWK THERAPEUTICS, INC. filed a patent application (US2025/053973) for “6-(6-(((1R,2R,3S,5S)-2-FLUORO-9-AZABICYCLO[3.3.1]NONAN-3YL) (METHYL)AMINO)PYRIDAZINE-3-YL)-2-METHYLBENZO[D]OXAZOL-5-OL TO TREAT HUNTINGTON'S DISEASE”. With publication no. WO/2026/101897, here are the other details related to the patent application:

Kind: Later publication of revised version of international search report [A9]

IPC: A61K 31/501

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....